Cidofovir and Amphotericin B Interaction

Drug interaction information between Cidofovir and Amphotericin B.

Cidofovir and Amphotericin B have a documented major interaction in FDA labeling.

FDA drug labeling documents a major-severity interaction between Cidofovir and Amphotericin B. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Cidofovir

Antiviral (Nucleotide Analog)

Drug B

Amphotericin B

Polyene Antifungal

How They Interact

Both drugs can cause damage to the kidneys. Combining them makes kidney injury much more likely.

FDA Label Information

Nephrotoxic agents Concomitant administration of cidofovir injection and agents with nephrotoxic potential [e.g., intravenous aminoglycosides (e.g., tobramycin, gentamicin, and amikacin), amphotericin B, foscarnet, intravenous pentamidine, vancomycin, and nonsteroidal anti-inflammatory agents] is contraindicated.

Frequently Asked Questions

What SPL severity band is on file for Cidofovir + Amphotericin B?

Compiled FDA labeling labels this pair major. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Cidofovir has 16 labeled pairs on file vs Amphotericin B's 12. In the major band specifically: Cidofovir has 5 (also Vancomycin, Gentamicin, Tobramycin, Amikacin); Amphotericin B has 1.

What mechanism field is on file for Cidofovir and Amphotericin B?

Both drugs can cause damage to the kidneys. Combining them makes kidney injury much more likely.

Cidofovir carries more major-labeled pairs than Amphotericin B

SPL source-record counts only. This page's band is major · classes on file: Cidofovir (Antiviral (Nucleotide Analog)); Amphotericin B (Polyene Antifungal).

Cidofovir has 5 major-labeled pairs vs Amphotericin B's 1.

Cidofovir

5 major · 0 moderate · 11 minor · 16 total

Amphotericin B

1 major · 2 moderate · 9 minor · 12 total

Amphotericin B has no other major-band peer in this dataset besides Cidofovir.

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.